| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/23/2005 | WO2004018997A3 Methods and compositions for modulating amyloid beta |
| 06/23/2005 | WO2004003151A3 Protein production methods and modified cells for use therein |
| 06/23/2005 | US20050137384 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 06/23/2005 | US20050136521 Separating a target protein (such as a recombinant protein produced in a cell culture) from a mixture by contacting mixture with a hydrophobic adsorbent comprising branched hydrocarbon functional groups in an aqueous salt solution and collecting the unbound flow-through fraction containing the target |
| 06/23/2005 | US20050136515 Nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of cell proliferative, inflammatory, nervous system and autoimmune diseases |
| 06/23/2005 | US20050136514 Related to sodium/glucose cotransporter subfamily; drug screening; biochips; host cells |
| 06/23/2005 | US20050136511 GABA B receptors |
| 06/23/2005 | US20050136491 Method of site specific labeling of proteins and uses therefor |
| 06/23/2005 | US20050136476 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof |
| 06/23/2005 | US20050136475 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/23/2005 | US20050136473 Breast specific nucleotide sequences for use as tools in diagnosis, prevention and treatment mammary gland cell proliferative disorders; rational drug design; antitumor agents |
| 06/23/2005 | US20050136467 Neuregulin fusion comprising epidermal growth factor domain for use in treatment and prevention of nervous system and neurodegenerative disorders |
| 06/23/2005 | US20050136462 Method for engineering nicking enzymes |
| 06/23/2005 | US20050136454 Cell-signaling assays |
| 06/23/2005 | US20050136403 Molecular characterists of non-small cell lung cancer |
| 06/23/2005 | US20050136402 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine |
| 06/23/2005 | US20050136057 Chimeric L chain comprising an L chain C region of a human antibody and an L chain V region of a mouse monoclonal antibody against a human parathyroid hormone related protein; may be used widely in hypercalcemia associated with various cancers |
| 06/23/2005 | US20050136054 Humanised antibodies |
| 06/23/2005 | US20050136051 Mixing a first molecule comprising IgG4 antibody heavy chain fragments capable of forming hinge region intra-heavy chain disulfide bonds with a second molecule comprising IgG4 antibody heavy chain fragments capable of forming hinge region intra-heavy chain disulfide bonds; incubating |
| 06/23/2005 | US20050136047 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 06/23/2005 | US20050136004 Biosynthesis of biodrug by inoculating an animal with a polypeptide; producing antibodies of cytokine suppressive antiinflammatory drugs; antibody is modified with polyoxyethylene glycol; inflammatory bowel disease, ulcerative colitis, Crohn's disease, arthritis, and psoriasis |
| 06/23/2005 | CA2549391A1 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 06/23/2005 | CA2548950A1 Methods for enhancing antibody activity |
| 06/23/2005 | CA2548929A1 Cell death inducing agent |
| 06/23/2005 | CA2546769A1 Production of diphtheria toxin |
| 06/23/2005 | CA2543257A1 Methods and compositions for delivering polynucleotides |
| 06/22/2005 | EP1544299A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 06/22/2005 | EP1544293A1 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same |
| 06/22/2005 | EP1543325A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 06/22/2005 | EP1543142A1 Production method for iturin a and its homologues |
| 06/22/2005 | EP1543128A2 Viral vectors containing recombination sites |
| 06/22/2005 | EP1543110A2 Mesoderm and definitive endoderm cell populations |
| 06/22/2005 | EP1543106A2 Methods and media for controlling sialylation of proteins produced by mammalian cells |
| 06/22/2005 | EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/22/2005 | EP1542725A2 Method of humanizing immune system molecules |
| 06/22/2005 | EP1542724A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 06/22/2005 | EP1196188B1 Vgf selective monoclonal antibodies and their use for treating vgf-related disorders |
| 06/22/2005 | EP1124849B1 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 06/22/2005 | EP1105360A4 Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules |
| 06/22/2005 | EP1073465B1 T cell inhibitory receptor compositions and uses thereof |
| 06/22/2005 | EP1017797B1 Non-primate lentiviral vectors and packaging systems |
| 06/22/2005 | EP0670892B1 Purification, composition and specificity of heparinase i, ii, and iii from flavobacterium heparinum |
| 06/22/2005 | CN1630731A Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 06/22/2005 | CN1630729A Method for the recombination of genetic elements |
| 06/22/2005 | CN1630722A Adapter-directed display systems |
| 06/22/2005 | CN1630708A Osteoclast-associated receptor |
| 06/22/2005 | CN1630665A Anti-A beta antibodies and their use |
| 06/22/2005 | CN1630664A Caspase-8 binding protein, its preparation and use |
| 06/22/2005 | CN1630663A Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 06/22/2005 | CN1630529A B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies |
| 06/22/2005 | CN1629290A A shrimp gene PIAV and polypeptides coded thereby |
| 06/22/2005 | CN1629185A Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 06/22/2005 | CN1628541A Method for producing protein mesenchyme originated from animal protein and food containing said protein mesenchyme |
| 06/22/2005 | CN1207387C Polypeptides and genes encoding same |
| 06/21/2005 | US6908991 Mutants; detergents; active materials; oxidation resistance |
| 06/21/2005 | US6908987 Comprises nucleotide sequences coding peroxisome proliferator activator receptor protein (PCG) for modulating thermogenesis in adipocytes and treating obesity |
| 06/21/2005 | US6908985 Heat-shock protein- binding proteins; useful in the regulation of physiological events in which one or more 70 kiloDalton heat-shock proteins (Hsp70) are involved, such as normal development, cellular stress responses, heart disease |
| 06/21/2005 | US6908984 Megakaryocytic protein tyrosine kinase I |
| 06/21/2005 | US6908756 For production of transgenic animal models; for treatment of Alzheimer's disease |
| 06/21/2005 | US6908740 Using chromatography to separate and sort subsets of peptides in protein mixtures |
| 06/21/2005 | US6908634 Transglutaminase soy fish and meat products and analogs thereof |
| 06/21/2005 | US6908617 Glycosylated modified primate lentivirus envelope polypeptides |
| 06/21/2005 | CA2304926C Robo: a family of polypeptides and nucleic acids involved in nerve guidance |
| 06/21/2005 | CA2145005C Monoclonal antibodies specific for tcf-ii |
| 06/21/2005 | CA2118498C A novel anti-neoplastic cytokine |
| 06/21/2005 | CA2049679C Hepatitis c assay utilizing recombinant antigens |
| 06/21/2005 | CA2044421C Squamous cell carcinoma-like immunoreactive antigen from human female urine |
| 06/19/2005 | WO2006083240A2 Microbially expressed xylanases and their use as feed additives and other uses |
| 06/19/2005 | CA2548723A1 Microbially expressed xylanases and their use as feed additives and other uses |
| 06/19/2005 | CA2494572A1 Cytochrome p450 24 (cyp24) monoclonal antibody and methods and uses thereof |
| 06/16/2005 | WO2005054467A1 EXPRESSION SYSTEM WITH THE USE OF MAMMALIAN β-ACTIN PROMOTER |
| 06/16/2005 | WO2005054465A1 Method of obtaining gene tag |
| 06/16/2005 | WO2005054438A2 Nucleic acid molecules containing recombination sites and methods of using the same |
| 06/16/2005 | WO2005054433A2 A novel “cleave-n-read” system for protease activity assay and methods of use thereof |
| 06/16/2005 | WO2005054296A1 Antibodies recognizing methyllysine, process for producing the same and utilization thereof |
| 06/16/2005 | WO2005054289A1 Process for purifying interferon beta |
| 06/16/2005 | WO2005053738A1 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens |
| 06/16/2005 | WO2005053516A2 Replication competent hepatitis c virus and methods of use |
| 06/16/2005 | WO2005040386A3 A vector modification for versatile use of expressed products |
| 06/16/2005 | WO2005005598A3 B. anthracis luxs and furanone inhibition of a1-2 quorum sensing |
| 06/16/2005 | WO2004035006A3 Methods and compositions for immunization against hiv |
| 06/16/2005 | US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/16/2005 | US20050131216 Reagents for detecting efavirenz |
| 06/16/2005 | US20050130942 (E)-2,4,6-trimethoxystyryl-4-methoxy-3-aminobenzylsulfone for example; cancer, tumors, multiple sclerosis, Pagets disease; antibody conjugates; target receptor tyrosine kinases and which arrest the Ras/Raf/MEK/ERK kinase cascade |
| 06/16/2005 | US20050130923 4'-thionucleosides and oligomeric compounds |
| 06/16/2005 | US20050130889 Analog further comprises an amino acid substitution wherein the cysteine residue at BPI amino acid position 132 is replaced by another amino acid; for treating gram-negative bacterial infections in a subject; bactericidal for gram-positive bacteria and mycoplasma; enhances effectiveness of antibiotics |
| 06/16/2005 | US20050130320 Using antibody imaging to determine concentration and distribution of proteins in cells and tissues; immunoaffinity chromatography |
| 06/16/2005 | US20050130304 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 06/16/2005 | US20050130286 For diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly cardiovascular diseases and/or disorders |
| 06/16/2005 | US20050130266 Prosuction of antibodies or (functionalized) fragments thereof derived from heavy chain immounogobulins of camelidae |
| 06/16/2005 | US20050130259 Expression vector comprising nucleotide sequences coding peptidylprolyl isomerase for use as tool to improve heterologous gene expression |
| 06/16/2005 | US20050130258 Nucleotide sequences coding heat shock protein which self-assembles into regular double-ring structures for use as component of multi-dimensional addressable arrays |
| 06/16/2005 | US20050130218 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/16/2005 | US20050130209 Expression vector comprising nucleotide sequences coding deoxyribonuclease for use as tool in treatment and prevention of cystic fibrosis |
| 06/16/2005 | US20050130203 Novel GABAB receptor DNA sequences |
| 06/16/2005 | US20050130160 Over-expression of extremozyme genes in pseudomonads and closely related bacteria |
| 06/16/2005 | US20050130156 Methods for making polynucleotides and purifying double-stranded polynucleotides |
| 06/16/2005 | US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening |
| 06/16/2005 | US20050130137 Vitronectin adhesion receptor for use in identifying modulators for treatment and prevention of cell proliferative and blood disorders |
| 06/16/2005 | US20050130135 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |